Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tectonic Therapeutic (TECX) Other Non Operating Income (2020 - 2026)

Tectonic Therapeutic (TECX) has 7 years of Other Non Operating Income data on record, last reported at -$113000.0 in Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 253.12% to -$113000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$200000.0, a 43.88% decrease, with the full-year FY2025 number at -$119000.0, up 76.71% from a year prior.
  • Other Non Operating Income reached -$113000.0 in Q1 2026 per TECX's latest filing, down from -$8000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for TECX hit a ceiling of $406000.0 in Q4 2023 and a floor of -$403000.0 in Q1 2024.
  • A 5-year average of -$29062.5 and a median of -$19500.0 in 2023 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 133.33% in 2023, then tumbled 2786.67% in 2024.
  • Tracing TECX's Other Non Operating Income over 5 years: stood at -$95000.0 in 2022, then soared by 527.37% to $406000.0 in 2023, then plummeted by 123.4% to -$95000.0 in 2024, then skyrocketed by 91.58% to -$8000.0 in 2025, then tumbled by 1312.5% to -$113000.0 in 2026.
  • Business Quant data shows Other Non Operating Income for TECX at -$113000.0 in Q1 2026, -$8000.0 in Q4 2025, and -$31000.0 in Q3 2025.